BC Week In Review | Apr 15, 2013
Company News

Nanogen, Becton Dickinson deal

The companies began a three-and-a-half year collaboration to develop infectious disease diagnostic tests. Becton will make an equity investment in Nanogen and will fund product development. Nanogen Inc. , San Diego, Calif.   Becton Dickinson and...
BC Week In Review | Apr 15, 2013
Company News

Nanogen other research news

Nanogen received a $710,000 grant from the U.S. Department of Justice to fund development of a portable genetic testing device based on microchips, to be used in forensics. Nanogen Inc., San Diego, Calif.   Product:...
BC Week In Review | Aug 10, 2009
Company News

Exact Sciences management update

Exact Sciences Corp. (NASDAQ:EXAS), Marlborough, Mass.   Business: Diagnostic, Cancer   Hired: Graham Lidgard as CSO, formerly SVP of R&D at Nanogen Inc.  ...
BC Week In Review | Jul 13, 2009
Company News

Nanogen, Elitech deal

Nanogen completed its previously announced sale of its assets to Elitech for $25.7 million (see BioCentury, May 18). Nanogen Inc. (Pink:NGEN), San Diego, Calif.   Elitech Group , Puteaux, France   Business: Diagnostic  ...
BC Week In Review | May 18, 2009
Company News

Nanogen, Elitech deal

Elitech will acquire substantially all of the assets of Nanogen for $25.7 million, and Nanogen filed a voluntary petition under Chapter 11 Bankruptcy with a motion seeking approval of the sale. Closing of the deal,...
BC Week In Review | Mar 9, 2009
Company News

Nanogen, Quest Diagnostics deal

Nanogen granted Quest a non-exclusive license to use its Minor Groove Binder (MGB) probe technology for in vitro molecular diagnostics. Nanogen received an undisclosed upfront payment and is eligible for royalties. Nanogen Inc. (NASDAQ:NGEN), San...
BC Week In Review | Jan 26, 2009
Company News

Nanogen, Elitech deal

Nanogen said its previously announced reverse-merger with Elitech is unlikely to close by March 31. As a result, Nanogen will explore other alternatives, including a restructured deal with Elitech or a transaction with a different...
BC Week In Review | Nov 17, 2008
Company News

Nanogen, Menarini sales and marketing update

Menarini's A. Menarini Diagnostics s.r.l. division will market Nanogen's in vitro diagnostic kits for infectious diseases in Europe. The kits use Nanogen's Minor Groove Binder (MGB) technology and have CE Mark approval. Menarini will launch...
BC Week In Review | Oct 27, 2008
Company News

Celera, Nanogen deal

The partners added in vitro cardiovascular and cancer diagnostics to Celera's rights under a 2004 license to Nanogen's Minor Groove Binder (MGB) and Eclipse Dark Quencher technologies. The original deal, between Celera and Epoch Biosciences...
BC Week In Review | Aug 18, 2008
Company News

Nanogen, Elitech deal

The companies will reverse-merge, combining Nanogen’s molecular and point-of-care diagnostics with Elitech’s in vitro diagnostics for the clinical chemistry and microbiology markets. Elitech shareholders will own 58.7-68.7% of the combined company, which will be headquartered...
Items per page:
1 - 10 of 213
BC Week In Review | Apr 15, 2013
Company News

Nanogen, Becton Dickinson deal

The companies began a three-and-a-half year collaboration to develop infectious disease diagnostic tests. Becton will make an equity investment in Nanogen and will fund product development. Nanogen Inc. , San Diego, Calif.   Becton Dickinson and...
BC Week In Review | Apr 15, 2013
Company News

Nanogen other research news

Nanogen received a $710,000 grant from the U.S. Department of Justice to fund development of a portable genetic testing device based on microchips, to be used in forensics. Nanogen Inc., San Diego, Calif.   Product:...
BC Week In Review | Aug 10, 2009
Company News

Exact Sciences management update

Exact Sciences Corp. (NASDAQ:EXAS), Marlborough, Mass.   Business: Diagnostic, Cancer   Hired: Graham Lidgard as CSO, formerly SVP of R&D at Nanogen Inc.  ...
BC Week In Review | Jul 13, 2009
Company News

Nanogen, Elitech deal

Nanogen completed its previously announced sale of its assets to Elitech for $25.7 million (see BioCentury, May 18). Nanogen Inc. (Pink:NGEN), San Diego, Calif.   Elitech Group , Puteaux, France   Business: Diagnostic  ...
BC Week In Review | May 18, 2009
Company News

Nanogen, Elitech deal

Elitech will acquire substantially all of the assets of Nanogen for $25.7 million, and Nanogen filed a voluntary petition under Chapter 11 Bankruptcy with a motion seeking approval of the sale. Closing of the deal,...
BC Week In Review | Mar 9, 2009
Company News

Nanogen, Quest Diagnostics deal

Nanogen granted Quest a non-exclusive license to use its Minor Groove Binder (MGB) probe technology for in vitro molecular diagnostics. Nanogen received an undisclosed upfront payment and is eligible for royalties. Nanogen Inc. (NASDAQ:NGEN), San...
BC Week In Review | Jan 26, 2009
Company News

Nanogen, Elitech deal

Nanogen said its previously announced reverse-merger with Elitech is unlikely to close by March 31. As a result, Nanogen will explore other alternatives, including a restructured deal with Elitech or a transaction with a different...
BC Week In Review | Nov 17, 2008
Company News

Nanogen, Menarini sales and marketing update

Menarini's A. Menarini Diagnostics s.r.l. division will market Nanogen's in vitro diagnostic kits for infectious diseases in Europe. The kits use Nanogen's Minor Groove Binder (MGB) technology and have CE Mark approval. Menarini will launch...
BC Week In Review | Oct 27, 2008
Company News

Celera, Nanogen deal

The partners added in vitro cardiovascular and cancer diagnostics to Celera's rights under a 2004 license to Nanogen's Minor Groove Binder (MGB) and Eclipse Dark Quencher technologies. The original deal, between Celera and Epoch Biosciences...
BC Week In Review | Aug 18, 2008
Company News

Nanogen, Elitech deal

The companies will reverse-merge, combining Nanogen’s molecular and point-of-care diagnostics with Elitech’s in vitro diagnostics for the clinical chemistry and microbiology markets. Elitech shareholders will own 58.7-68.7% of the combined company, which will be headquartered...
Items per page:
1 - 10 of 213